Nimucitinib
Based on 1 Customer Validation
Nimucitinib is a selective JAK inhibitor with potent tear secretion-promoting activity. Nimucitinib downregulates relevant signal transduction pathways by inhibiting the catalytic activity of JAK family tyrosine kinases. Nimucitinib promotes tear secretion in rabbits and inhibits corneal injury in rats. Nimucitinib can be used in dry eye-related research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.27%
- CAS No.: 2740557-24-6
- Formule: C25H26F2N6O2
- Masse moléculaire:480.51
-
Stockage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
Epigenetics Compound Library
HY-L005
-
Immunology/Inflammation Compound Library
HY-L007
-
JAK/STAT Compound Library
HY-L008
-
Kinase Inhibitor Library
HY-L009
-
Protein Tyrosine Kinase Compound Library
HY-L016
-
Stem Cell Signaling Compound Library
HY-L017
-
Anti-Aging Compound Library
HY-L034
-
Differentiation Inducing Compound Library
HY-L038
-
Reprogramming Compound Library
HY-L039
-
Anti-Breast Cancer Compound Library
HY-L074
-
Anti-Lung Cancer Compound Library
HY-L075
-
Anti-Pancreatic Cancer Compound Library
HY-L077
-
Anti-Blood Cancer Compound Library
HY-L079
-
Anti-Obesity Compound Library
HY-L087
-
Anti-Liver Cancer Compound Library
HY-L101
-
Anti-Prostate Cancer Compound Library
HY-L124
-
Cancer Stem Cells Compound Library
HY-L135
-
Autoimmune Disease Compound Library
HY-L156
-
Highly Selective Inhibitors Library
HY-L158
-
Anti-Hematopathy Compound Library
HY-L171
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
Protein Kinase Compound Library
HY-L196
-
High-Throughput Bioactive Compound Library
HY-L205
-
Anti-Rheumatic Arthritis Compound Library
HY-L210
-
Posttranslational Modification Library
HY-L226
Activité biologique
Nimucitinib (0.01% solution, administered via ocular instillation, 50 μL per dose, four times daily for 10 consecutive days) promotes tear secretion in a rabbit model of atropine-induced dry eye[1].
Nimucitinib (0.003-0.01% solution; eye drop; 6 times per day for 11 consecutive days; 5 μL each time) inhibits corneal injury in a rat model of dry eye induced by extraorbital lacrimal gland excision[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:JW white rabbit (male, weight ~2 kg)[1]
-
Dosage:0.001% solution; 0.01% solution
-
Administration:ocular instillation; single dose; 50 μL
-
Result:Increased tear volume by 131% compared to pre-administration in the 0.001% solution group.
Increased tear volume by 168% compared to pre-administration in the 0.01% solution group.
-
Animal Model:JW white rabbit (male, weight ~2 kg, atropine-induced dry eye model)[1]
-
Dosage:0.01% solution
-
Administration:ocular instillation; 4 times daily; 10 days; 50 μL
-
Result:Increased tear volume by 151% compared to pre-administration.
-
Animal Model:SD rat (male, 6 weeks old, extraorbital lacrimal gland excision-induced dry eye model)[1]
-
Dosage:0.003% solution; 0.01% solution
-
Administration:ocular instillation; 6 times daily; 11 days; 5 μL
-
Result:Resulted in a corneal damage score of 13.0 in the 0.003% solution group.
Resulted in a corneal damage score of 10.5 in the 0.01% solution group.
Chemical Information
-
CAS No. 2740557-24-6
-
Appearance Solid
-
Masse moléculaire 480.51
-
Formule C25H26F2N6O2
-
Color Off-white to light yellow
-
SMILES
FC1=CC(F)=CC(CNC2=CC(NC3=CC(NC([C@H]4CCCNC4)=O)=CC=C3)=NC=C2C(N)=O)=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
DMSO : 125 mg/mL (260.14 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (270 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.0811 mL | 10.4056 mL | 20.8112 mL | 52.0281 mL |
| 5 mM | 0.4162 mL | 2.0811 mL | 4.1622 mL | 10.4056 mL | |
| 10 mM | 0.2081 mL | 1.0406 mL | 2.0811 mL | 5.2028 mL | |
| 15 mM | 0.1387 mL | 0.6937 mL | 1.3874 mL | 3.4685 mL | |
| 20 mM | 0.1041 mL | 0.5203 mL | 1.0406 mL | 2.6014 mL | |
| 25 mM | 0.0832 mL | 0.4162 mL | 0.8324 mL | 2.0811 mL | |
| 30 mM | 0.0694 mL | 0.3469 mL | 0.6937 mL | 1.7343 mL | |
| 40 mM | 0.0520 mL | 0.2601 mL | 0.5203 mL | 1.3007 mL | |
| 50 mM | 0.0416 mL | 0.2081 mL | 0.4162 mL | 1.0406 mL | |
| 60 mM | 0.0347 mL | 0.1734 mL | 0.3469 mL | 0.8671 mL | |
| 80 mM | 0.0260 mL | 0.1301 mL | 0.2601 mL | 0.6504 mL | |
| 100 mM | 0.0208 mL | 0.1041 mL | 0.2081 mL | 0.5203 mL |
Nimucitinib Related Classifications
HY-148785 Related Classifications
Powered by Bioz